Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Lupus drug shows surprise phase III success

July 23, 2009 Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus

 GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …
News

Effient ‘unlikely’ to takeover from Plavix

July 23, 2009 Research and Development, Sales and Marketing Effient, cv

News

Kennedy calls for overhaul of NICE processes

July 23, 2009 Research and Development, Sales and Marketing NICE, hta

NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …
News

NICE approves MabThera for leukaemia

July 22, 2009 Research and Development, Sales and Marketing MabThera, NICE

NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …
News

Phase Forward buys Covance unit for $10m

July 21, 2009 Research and Development CRO, Phase Forward

US clinical data management specialist Phase Forward is planning to get bigger in interactive response technologies (IRT) via a $10 …
News

Roche eyes expanded colon cancer label for Xeloda

July 20, 2009 Research and Development, Sales and Marketing Roche, Xeloda

Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …
News

Jubilant makes solid start to fiscal 2010

July 20, 2009 Manufacturing and Production, Research and Development Jubilant

Indian contract research and manufacturing services company Jubilant Organosys shrugged off the effects of the economic downturn with a buoyant …
News

Drug repositioning a ‘key strategy’ for pharma

July 17, 2009 Research and Development Datamonitor, strategy

With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more …
News

Merck signs anticoagulant collaboration

July 17, 2009 Research and Development, Sales and Marketing Merck, cv

Merck has continued the trend of big pharma companies signing on the dotted line with small biotech outfits in a …
News

Effient approved in US

July 17, 2009 Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly

Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …
News

NICE bypassed in radical innovation boost

July 16, 2009 Research and Development, Sales and Marketing ABPI, Blueprint, NICE, hta

Ministers have sidestepped NICE in their bid to boost innovation in life sciences, and said certain medicines can made available …
News

Oxford BioMedica encouraged by phase I/II Parkinson’s trial

July 15, 2009 Research and Development Oxford BioMedica, Prosavin

News

Poor antigen yields limiting H1N1 vaccine supplies, says WHO

July 15, 2009 Manufacturing and Production, Research and Development h1n1, vaccines

Inadequate production capacity means that the poorest countries in the world will be denied access to vaccines for H1N1 influenza, …
News

Blueprint to fast track innovative drugs and devices

July 14, 2009 Research and Development, Sales and Marketing ABPI, Blueprint, NHS

A new 'Blueprint' to put innovation at the heart of the NHS and help support the UK life sciences sector …
News

Charles River restructures as president sets retirement date

July 14, 2009 Research and Development CRO, Charles River

Charles River Laboratories has unveiled a major shake-up its business and sales activities as part of a reorganisation prompted by …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026